A Conjugate between Lqh-8/6, a Natural Peptide Analogue of Chlorotoxin, and Doxorubicin Efficiently Induces Glioma Cell Death.
Lqh-8/6
apoptosis
chlorotoxin
click chemistry
conjugation
doxorubicin
glioma cells
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
17 Oct 2022
17 Oct 2022
Historique:
received:
05
09
2022
revised:
10
10
2022
accepted:
11
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
Natural peptides isolated from animal venoms generally target cell surface receptors with high affinity and selectivity. On many occasions, some of these receptors are over-expressed in cancer cells. Herein, we identified Lqh-8/6 as a natural peptide analog of chlorotoxin, a proven and useful compound for the diagnosis and treatment of glioma. Lqh-8/6 and two other natural analogues were chemically synthesized for the first time and evaluated for their ability to label, detect and prevent glioma growth in vitro. We demonstrate that a biotinylated version of Lqh-8/6 allows both the labeling of glioma cell lines and the detection of glioma in brain sections of glioma allograft Fisher rats. Lqh-8/6 has intrinsic anti-invasive properties but is non-toxic to glioma cells. To confer anti-tumor properties to Lqh-8/6, we chemically coupled doxorubicin to the glioma-targeting peptide using click chemistry. To this end, we successfully chemically synthesized Lqh-8/6-azide and doxorubicin-alkyne without impairing the toxic nature of doxorubicin. The toxin-drug conjugate efficiently promotes the apoptosis of glioma cells in vitro. This example contributes to the concept that animal venom peptides constitute exquisite warheads for delivering toxic chemical conjugates, a parallel to the popular concept of antibody-drug conjugates for the treatment of cancer.
Identifiants
pubmed: 36289865
pii: biomedicines10102605
doi: 10.3390/biomedicines10102605
pmc: PMC9599068
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Agence Nationale de la Recherche
ID : ANR-11-LABX-0015
Références
Biochem J. 2004 Mar 15;378(Pt 3):717-26
pubmed: 14674883
Mol Pharm. 2015 Dec 7;12(12):4336-48
pubmed: 26465677
Handb Clin Neurol. 2016;134:381-97
pubmed: 26948367
Lancet. 2003 Jan 25;361(9354):323-31
pubmed: 12559880
Biochem Biophys Res Commun. 2010 Jun 11;396(4):908-14
pubmed: 20457128
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
Cancer Lett. 2010 May 28;291(2):158-66
pubmed: 19906483
Apoptosis. 2009 Nov;14(11):1352-65
pubmed: 19731037
Forum (Genova). 2003;13(1):61-75
pubmed: 14732888
Biochem Biophys Res Commun. 2010 Jan 1;391(1):419-25
pubmed: 19914216
Cell Mol Immunol. 2018 Aug;15(8):737-739
pubmed: 29553137
ACS Nano. 2010 Aug 24;4(8):4587-94
pubmed: 20731441
Neuroscience. 1998 Apr;83(4):1161-73
pubmed: 9502255
J Mater Chem B. 2016 Jan 7;4(1):32-36
pubmed: 26835125
J Neurosci. 1999 Jul 15;19(14):5942-54
pubmed: 10407033
Int J Biochem Cell Biol. 2016 Aug;77(Pt A):15-22
pubmed: 27210502
Cancer Chemother Pharmacol. 1991;29(2):105-11
pubmed: 1760851
J Biol Chem. 2010 Feb 12;285(7):4366-74
pubmed: 20018898
PLoS One. 2011;6(7):e22284
pubmed: 21811581
Toxicon. 1991;29(11):1403-8
pubmed: 1726031
Nano Lett. 2005 Jun;5(6):1003-8
pubmed: 15943433
Small. 2009 Feb;5(2):256-64
pubmed: 19089837
J Neurosci. 2003 Jul 2;23(13):5572-82
pubmed: 12843258
Cancer Lett. 2009 Nov 18;285(1):28-38
pubmed: 19523755
Mol Pharm. 2011 Apr 4;8(2):375-86
pubmed: 21241067
J Inorg Biochem. 2012 May;110:58-63
pubmed: 22465700
Am J Physiol. 1993 Feb;264(2 Pt 1):C361-9
pubmed: 8383429
J Med Chem. 2010 Apr 8;53(7):2814-24
pubmed: 20210346
Cancer J. 2012 Jan-Feb;18(1):26-31
pubmed: 22290254
Glia. 2002 Aug;39(2):162-73
pubmed: 12112367
J Biol Chem. 2003 Feb 7;278(6):4135-44
pubmed: 12454020
Cancer Res. 2007 Jul 15;67(14):6882-8
pubmed: 17638899
JAMA. 2013 Nov 6;310(17):1842-50
pubmed: 24193082
Anticancer Res. 2015 Mar;35(3):1229-35
pubmed: 25750269
Biochim Biophys Acta. 2014 Oct;1843(10):2356-64
pubmed: 24667409
Cancer Res. 1998 Nov 1;58(21):4871-9
pubmed: 9809993
Sci Rep. 2016 Feb 02;6:19799
pubmed: 26831010
Peptides. 2011 Apr;32(4):656-63
pubmed: 21262299
Technol Cancer Res Treat. 2008 Dec;7(6):497-516
pubmed: 19044329
Ann Oncol. 2012 Sep;23 Suppl 10:x33-40
pubmed: 22987986
Mol Pharmacol. 2000 Apr;57(4):679-86
pubmed: 10727512
J Med Chem. 2006 Nov 16;49(23):6908-16
pubmed: 17154520
J Med Chem. 2011 Feb 10;54(3):782-7
pubmed: 21210710
Int J Mol Sci. 2015 Nov 19;16(11):27730-40
pubmed: 26610471
Nature. 2018 Aug;560(7717):243-247
pubmed: 30069053
Cancer Res. 2013 Jan 15;73(2):804-12
pubmed: 23151901
Acta Neurochir (Wien). 2011 Jun;153(6):1211-8
pubmed: 21479583
Curr Top Med Chem. 2015;15(13):1196-208
pubmed: 25858130
Cancer Cell. 2009 Dec 8;16(6):510-20
pubmed: 19962669
Sci Transl Med. 2010 Jun 2;2(34):34ps26
pubmed: 20519716
Mol Neurobiol. 2020 May;57(5):2461-2478
pubmed: 32152825
Front Oncol. 2015 Jan 29;5:12
pubmed: 25688335
Pharm Res. 2009 Apr;26(4):836-45
pubmed: 19083085
J Neurooncol. 2012 May;107(3):457-62
pubmed: 22108716
ACS Nano. 2016 Feb 23;10(2):2509-20
pubmed: 26745323
Neurosurg Clin N Am. 2021 Jan;32(1):1-8
pubmed: 33223018
Biomaterials. 2011 Mar;32(9):2399-406
pubmed: 21185076
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Biomaterials. 2009 Feb;30(4):649-57
pubmed: 18990439
Eur J Biochem. 1997 May 15;246(1):218-27
pubmed: 9210487
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W485-91
pubmed: 19443448
Toxins (Basel). 2015 Mar 27;7(4):1079-101
pubmed: 25826056
Bioorg Med Chem Lett. 2005 Nov 15;15(22):5071-5
pubmed: 16168650